Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-18

Clinical Trial Update: An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal Fusion [Phase 2, Phase 3]

View source ↗

Summary

Open-label Phase 2/3 trial of clevidipine for controlled hypotension during spinal fusion has completed, and results have been posted. The study focused on pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLEVIPREX (clevidipine)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Neuromuscular Scoliosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-02-18